ANH NGUYEN: Open Payments
NPI 1508640582 · ROSEMEAD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$735 in 17 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $240 · 2025 $735
Food & beverage: $735
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 5 | $287 |
| Novartis Pharmaceuticals Corporation | 7 | $194 |
| Janssen Biotech, Inc. | 2 | $158 |
| UCB, Inc. | 1 | $50 |
| GlaxoSmithKline, LLC. | 1 | $24 |
| AstraZeneca Pharmaceuticals LP | 1 | $23 |
Products named: COSENTYX, TREMFYA, KRYSTEXXA, EVENITY, BENLYSTA, BREZTRI, OTEZLA.
Industry payments across CA — which companies pay providers there.
